International Pharmaceutical Industry

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Current Features

Real-Time LCA: From Sustainability Reporting to Sustainable Action

Though pharmaceutical organisations have more sustainability data than ever before, the value of this data often remains limited to one-off reporting exercises, rath...

26 June 2026 Current Features | Volume 18, Issue 2

Continue Reading →

Current Features

Expert Roundtable: Navigating the Next Phase of Low Carbon pMDI Development

In May 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the world's first low carbon pressurised Metered Dose Inhaler (pMDI). For an...

26 June 2026 Current Features | Volume 18, Issue 2

Continue Reading →

Current Features

Inside the Spray: How In Vitro Tools Reveal What’s Really Happening When Your Product Meets a Patient

When a nasal spray or inhaler works well in a patient, a lot of things must go right. The formulation must stay stable. The device must be atomised correctly. The re...

26 June 2026 Current Features | Volume 18, Issue 2

Continue Reading →

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Current Features

Real-Time LCA: From Sustainability Reporting to Sustainable Action

Though pharmaceutical organisations have more sustainability data than ever before, the value of this data often remains limited to one-off reporting exercises, rath...

26 June 2026 Current Features | Volume 18, Issue 2

Continue Reading →

Current Features

Expert Roundtable: Navigating the Next Phase of Low Carbon pMDI Development

In May 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the world's first low carbon pressurised Metered Dose Inhaler (pMDI). For an...

26 June 2026 Current Features | Volume 18, Issue 2

Continue Reading →

Current Features

Inside the Spray: How In Vitro Tools Reveal What’s Really Happening When Your Product Meets a Patient

When a nasal spray or inhaler works well in a patient, a lot of things must go right. The formulation must stay stable. The device must be atomised correctly. The re...

26 June 2026 Current Features | Volume 18, Issue 2

Continue Reading →